Your browser doesn't support javascript.
loading
[The effects of sequence of radiotherapy and chemotherapy on prognosis of patients with early-stage extranodal NK/T cell lymphoma (nasal type) and its individualized application].
Yang, J; Yang, Y; Qi, S N; Wu, T; He, X; Zhang, L L; Wu, G; Qu, B L; Qian, L T; Hou, X R; Zhang, F Q; Qiao, X Y; Wang, H; Li, G F; Zhu, Y; Cao, J Z; Wu, J X; Zhu, S Y; Shi, M; Su, H; Zhang, X M; Zhang, H L; Huang, H Q; Zhang, Y J; Song, Y Q; Zhu, J; Wang, Y; Li, Y X.
Afiliação
  • Yang J; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing 100021, China.
  • Yang Y; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing 100021, China.
  • Qi SN; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing 100021, China.
  • Wu T; Department of Lymphoma, Affiliated Hospital of Guizhou Medical University, Guizhou Cancer Hospital, Guiyang 550000, China.
  • He X; Department of Radiation Oncology Jiangsu Cancer Hospital, Nanjing 210009, China.
  • Zhang LL; Oncology Center of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430023, China.
  • Wu G; Oncology Center of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430023, China.
  • Qu BL; Department of Radiation Oncology, the First Medical Center of PLA General Hospital, Beijing 100853, China.
  • Qian LT; Department of Radiation Oncology, the Affiliated Provincial Hospital of Anhui Medical University, Hefei 230001, China.
  • Hou XR; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing 100730, China.
  • Zhang FQ; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing 100730, China.
  • Qiao XY; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
  • Wang H; Department of Radiation Oncology, Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
  • Li GF; Department of Radiation Oncology, Beijing Hospital, National Geriatric Medical Center, Beijing 100730, China.
  • Zhu Y; Department of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou 310022, China.
  • Cao JZ; Department of Radiation Oncology, Shanxi Cancer Hospital and the Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan 030001, China.
  • Wu JX; Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Fuzhou 350014, China.
  • Zhu SY; Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha 410013, China.
  • Shi M; Department of Radiation Oncology, Xijing Hospital of Air Force Military Medical University, Xi'an 710032, China.
  • Su H; Department of Lymphoma & Hematologic Oncology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.
  • Zhang XM; Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin 300060, China.
  • Zhang HL; Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin 300060, China.
  • Huang HQ; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
  • Zhang YJ; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
  • Song YQ; Department of Lymphoma & Hematologic Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Zhu J; Department of Lymphoma & Hematologic Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Wang Y; Department of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Hospital, Chongqing 400000, China.
  • Li YX; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing 100021, China.
Zhonghua Yi Xue Za Zhi ; 101(17): 1232-1238, 2021 May 11.
Article em Zh | MEDLINE | ID: mdl-34865391

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Extranodal de Células T-NK Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: Zh Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Extranodal de Células T-NK Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: Zh Ano de publicação: 2021 Tipo de documento: Article